(IN BRIEF) Roche has launched the cobas MPX-E assay, a multiplex molecular diagnostic test capable of detecting HIV, Hepatitis B, Hepatitis C, and Hepatitis E simultaneously in a single workflow. Available in CE mark–accepting markets, the assay is designed to … Read the full press release
Posted in Healthcare, Industrial, Pharma & Biotech, Science, Switzerland, Technology
Tagged blood donor screening, CE Mark, cobas 5800, cobas 8800, cobas MPX-E, cobas x800 systems, cobas® 6800, HBV, HCV, Healthcare Innovation, Hepatitis B, hepatitis C, Hepatitis E, HEV, HIV, In Vitro Diagnostics, laboratory automation, Matt Sause, Molecular Diagnostics, NAT blood screening, PCR testing, Roche, Roche Diagnostics, Roche Introduces cobas MPX-E Test to Enhance Laboratory Efficiency and Strengthen Global Blood Safety Standards, Roche Launches High-Throughput Multiplex Diagnostic Assay to Streamline Detection of HIV and Hepatitis Viruses, viral detection
(IN BRIEF) The University of Liverpool and Imperial College London, working with international partners, have published the first global systematic review of hepatitis B care, commissioned by WHO and covering over 1.7 million patients across 50 countries. The analysis found … Read the full press release
Posted in Business, Education, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Non Profit, Science, Technology, United Kingdom
Tagged Alexander Stockdale, antiviral therapy, chronic hepatitis B, decentralised healthcare, diagnosis gaps, global elimination target 2030, global health, Hepatitis B, HIV care models, Imperial College London, maternal health, partnership, Patient Retention, Philippa Easterbrook, postpartum care, primary care, The Lancet Gastroenterology & Hepatology, treatment initiation, University of Liverpool, WHO, World Health Organization
(IN BRIEF) Roche has unveiled Elecsys® HBeAg quant, a new immunoassay designed to detect the presence and quantity of the hepatitis B e antigen (HBeAg) in human serum and plasma. This diagnostic tool simplifies the process for both clinicians and … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology
Tagged diagnosis, Elecsys®, HBeAg Quant Test, Hepatitis B, Matt Sause, monitoring, Roche
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?